Repro-Med Systems, Inc. (NASDAQ:REPR) Director Joseph M. Jr. Manko acquired 32,500 shares of the stock in a transaction dated Monday, October 10th. The shares were purchased at an average cost of $0.43 per share, with a total value of $13,975.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Repro-Med Systems, Inc. (NASDAQ:REPR) opened at 0.42 on Friday. Repro-Med Systems, Inc. has a 52 week low of $0.28 and a 52 week high of $0.59. The stock’s 50 day moving average is $0.41 and its 200 day moving average is $0.39. The company has a market capitalization of $15.95 million and a P/E ratio of 84.00.
About Repro-Med Systems
REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.
Receive News & Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.